ZOLL AED 3 BLS,Full article: IMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation,柏瑞醫- SYSTEX 精誠資訊,专业诊断产品示例04 - 北京人福医疗器械有限公司,生命信息解决方案– Shenzhen Envisen Industry Co. Ltd,